Humanigen Inc (HGEN) stock forecast for 2024, 2025, 2030

Share this:
Disclaimer

Disclaimer

All information on this page is published ‘as is’ and for information purposes alone. The information is not intended for trading or advice of financial, investment, tax, legal, accounting or any kind of nature. Before starting to trade, please contact your broker or a financial advisor to check the quotes, evaluate forecasts or the opinion of the author of the article. Our company is not an investment consultant, financial advisor or a broker for transactions involving securities. No information shall be viewed as investment advice, recommendation or offer of our company to buy, hold or sell securities or financial products. Our company does not provide guarantees and does not express opinions about appropriateness or suitability of investments.

No information shall be regarded as investment advice (general or individual). Financial products or transactions mentioned in such information may not be suitable for your investment portfolio and may not meet your investment targets and expectations. You are solely responsible for any decision regarding financial products or transactions and you shall independently determine whether they are suitable for you, taking into account your interests, investment targets, investment horizon and tolerable risk level. Our company shall not bear any responsibility for the losses caused by financial transactions or investments in financial products mentioned on our website. We do not recommend making investment decisions guided solely by this information.

The information on our website is provided by stock exchanges, brokers and other content providers, and, in some cases, may arrive with a delay. Our company does not verify such information and shall waive any liability related to it.

Our company and our information and content providers, financial exchanges, brokers and also all affiliated companies and business partners: a) expressly waive any responsibility for the accuracy, validity and completeness of any data; b) shall not be liable for any mistakes, omissions or other flaws on such information, for delays and interruptions in their display, as well as for actions taken based on such information. Neither our company nor our information providers shall be liable for the damage caused by the use of the information provided here. The term ‘business partners’ in this case shall not imply any partnership or agency relationships as well as the creation of a joint venture between our company and any other organization.

You hereby confirm that you shall not copy, modify, reformat, download, store, reproduce, process, transfer or distribute any information published here or use such information for commercial purposes without prior written consent.

Traders Union as well as its external information and content providers retain exclusive copyright to the provided information.

Our company shall not be liable for the products and services advertised on our website.

General websites Disclaimer:

Traders Union (tradersunion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it. Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

Start Trading 3,000+ Stocks Online
Your capital is at risk.

eToro - Best Broker to Trade Stocks Online

Humanigen Inc (HGEN) is a biopharmaceutical company developing proprietary immunomodulatory and immuno-oncology antibodies. The company stock is listed on NASDAQ.

1

Current HGEN stock price $0.0002.

2

According to analytical forecasts, the price of HGEN stocks may reach $0.0002 by the end of 2024, and it is expected to be - $0.0002 by the end of 2029.

3

Based on technical analysis indicators, the recommendation for the 1H (one-hour) timeframe is Strong Sell, and for the 1D (one-day) timeframe - Strong Sell.

The stock price hit the all-time high in 2020 at $34 against the hopes of investors for development of COVID-19 treatment. The failure of results and clinical trials collapsed the stock price below $0.5. Can HGEN return to an upward trend?


This page features financial multipliers based on statements, data of technical indicators, fundamental forecasts and other information to help you determine your investment goals and terms.

NOTE!

On this page, you will find the latest information about current prices, updated and new forecasts for short and long-term intervals:

  • Asset quotes are updated every minute.
  • Price chart is updated every minute.
  • Technical indicator data is updated according to the time frame. For example, on M5, the data is updated every 5 minutes.
  • Medium and long-term forecasts are updated every hour.
  • Financial reporting data is updated quarterly.

Data for fundamental analysis of Humanigen Inc stock

In this section you will learn about the basic statistics of Humanigen Inc and other data for fundamental analysis. The section provides key financial indicators of the company as well as main multipliers.


Basic indicators contain information about the company that provides a general idea of its operation and position in the market.



Basic indicators
Industry
Biotechnology
Sector
Healthcare
Number of employees
6
Latest dividend payment date
-
Dividend amount
-
Market cap
23.82K
Net income
-4.18M
52-week low
-
52-week high
0.21
Beta coefficient
-1.05


Key financial indicators of Humanigen Inc contain general information about the financial condition of the company. For analysis, current values are compared to the values of previous periods, forecasts and indicators of competitors.



Financial indicators
Gross profit
-
Net income
-4.18M
Accounts payable
38.39M
Accounts receivable
-
EPS
-0.04
Long-term debt
-


Multipliers are coefficients, derivative financial indicators that allow for assessing financial stability, the degree of undervaluation, overvaluation, investment attractiveness of a company, company’s performance, and forecasting an increase or decline in the value of shares.



Multipliers
EV
-3.06M
EV/R
-1.8
P/E
0
EV/EBITDA
0.05
EBITDA
-4.16M
P/S
0.01
Profit margin
-
P/B
0
Operating margin
-19.16
Total debt
-
Annual revenue per share
0.02
Debt to equity ratio
-
ROE
1.51
Current liquidity coefficient
0.09
ROA
-0.85
Ratio of short positions to the total shares in circulation
0.04
Forward P/E
0
Forward annual dividend yield
-
PEG
0
Operating cash flow
-64.32M

Humanigen Inc stock forecast for today, HGEN signals for 1 week

Short-term HGEN price forecast (signals) are prepared by Traders Union based on the technical analysis of moving averages and indicators for each timeframe (interval) separately. Select the timeframe that you need to learn the HGEN forecast for today.

NOTE!

Signals may differ on different time frames. If you want to buy Humanigen Inc (HGEN) and hold the stock for longer than one week, it is best to use the signals on daily and weekly timeframes. Timeframes from 5 minutes to 1 hour are best suitable for short-term transactions!

Invest in US Stocks
Your capital is at risk.

Best commission-free broker for stock investments

Suitable for those who want to invest in the stocks for the long term

Humanigen Inc Stock forecast for 1 year. What will the HGEN price be?

In this section, you will learn the following analyst forecasts:


  • Quarterly and annual earnings per share (EPS) forecast.

The forecasts are made based on surveys of top managers of companies and analysts. Also, current financial indicators of companies and projected indicators were taken into account.

Recommendations of analysts
Strong Buy 0
Buy 0
Hold 2
Sell 0
Strong Sell 0
Overall recommendation Hold
Quarterly and annual earnings per share (EPS) forecast, USD
Parameter Current quarter forecast 12-month forecast
Maximum forecast -0.04 0
Minimum forecast -0.04 0
Parameter Current quarter forecast 12-month forecast
Average forecast -0.04 0
Average forecast value 1 year ago -0.23

Indicator Based Technical Analysis of HGEN/USD

To find a better entry point, also find out what TradingView technical analysis tool signals for the Humanigen Inc (HGEN/USD) price. "Sell" or "Strong Sell" means that most of the signals are bearish. "Buy" or "Strong Buy" means that most of the signals are bullish. For short-term signals, it is recommended to use settings from 15 minutes to 2 hours. For long-term signals, it is recommended to use settings from 4 hours to 1 week.

HGEN/USD Chart Online

What Humanigen Inc price will be in 5 years and 12 years – prediction by years

According to the Traders Union long-term price forecast Humanigen Inc (HGEN) can reach $0.0002 by 2025, $0.0002 by 2030, $0.0002 by 2034.

Year Price in the middle of the year Price at the end of the year
2024 $0.0002 $0.0002
2025 $0.0002 $0.0002
2026 $0.0002 $0.0002
2027 $0.0002 $0.0002
2028 $0.0002 $0.0002
2029 $0.0002 $0.0002
2030 $0.0002 $0.0002
2031 $0.0002 $0.0002
2032 $0.0002 $0.0002
2033 $0.0002 $0.0002
2034 $0.0002 $0.0002
2035 $0.0002 $0.0002

Alternative long-term price forecasts by independent analytical platforms

Here, you will find long-term stock price forecasts provided by independent analytical resources. The price forecasting methodologies they use vary, which is why the forecasts may differ substantially from each other. We recommend focusing on the average price.


According to the price forecast by Walletinvestor analysts, the Humanigen Inc stock will be priced at $0.000001 at the beginning of 2025, and $0.000001 at the beginning of 2028.


What Humanigen Inc (HGEN) news can influence the price in the future?

Results of clinical trials, certification of developed products and the launch of its mass production are the key factors influencing stock prices of biopharmaceutical companies. This is also about certification beyond the domestic market. Humanigen has big issues in this respect. In the middle of 2022, the company stock price dropped 78% after the company’s COVID-19 treatment failed in a late-stage clinical trial. A similar situation was observed in 2021. Only a unique breakthrough development can save the company, whose share price plunged from $25-30 to $0.15-0.20.

Latest exchange rates online

Price prediction methodology

The following tools and instruments were used for making the prediction:


Basic instruments of technical analysis. The forecast relies on basic technical indicators. The analysis was performed mostly on medium and long-term time frames for more accurate results.

Chart analysis. Analysis comprises a review of key levels of support, resistance, trend lines, as well as patterns formed on different time frames.

Statistical tools help evaluate a probability of a fundamental factor that could impact the price, its nature and intensity of impact.

Methods of mathematical and statistical analysis; modeling, adaptive forecasting methods.

Expert opinions and consensus forecast.

NOTE!

This forecast is based on current information and data of previous periods. Emergence of strong fundamental factors capable of radically changing the overall market trend and subsequent price trend is possible. The forecasts are updated regularly based on the latest data.

This article is created for informational purposes only and does not constitute investment advice. Be aware of the high volatility of cryptocurrencies and consider these risks when making investment decisions.

FAQs

Is Humanigen Stock a good Buy?

Until the company shows positive results of clinical trials of its treatments, there is no sense in buying its stock.

Why is Humanigen stock dropping?

The main reason is absence of positive results, namely failed clinical trials of the products the company is developing.

Does Humanigen Inc have a future?

Everything depends on the results of studies, clinical trials and certification of products.

What will Humanigen Inc stock be worth in 2030?

It is difficult to forecast the stock price in the long term. If the company fails to show results, its stock will move to the category of “shit” shares. Then, three scenarios are possible: bankruptcy, existence without prospects, and acquisition. If the company succeeds in offering a competitive product in the pharmaceutical market, its stock price could soar more than tenfold.